This inventor holds 3 USPTO granted patents. Top assignees: Clonex Development, Inc., Cdi Bioscience. Active years: 2003-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2010
Title: Victor Levenson: Innovator in Protein Yield Enhancement
Introduction
Victor Levenson is a notable inventor based in Oak Park, IL (US). He has made significant contributions to the field of biotechnology, particularly in methods for enhancing protein production from cell cultures. With a total of 3 patents to his name, Levenson's work has implications for both commercial and research applications.
Latest Patents
Levenson's latest patents focus on innovative methods and compositions for increasing protein yield from cell cultures. One of his key inventions involves switching cells from a replicative to a productive state, known as the RP switch. This process extends protein biosynthesis by inducing a pseudo-senescent state in the cells. The pseudo-senescent state can be achieved by transforming the cells with a vector that expresses a cell cycle inhibitor. This approach allows for the maintenance of cells in culture for longer periods without causing cell death. His inventions enable controlled enhancement of protein biosynthetic productivity, which is valuable for various commercial and research purposes.
Career Highlights
Throughout his career, Victor Levenson has worked with several companies, including Clonex Development, Inc. and Cdi Bioscience. His experience in these organizations has contributed to his expertise in the field of biotechnology and protein production.
Collaborations
Levenson has collaborated with notable professionals in his field, including Todd Bucciarelli and Thomas Primiano. These collaborations have likely enriched his research and development efforts.
Conclusion
Victor Levenson is a prominent inventor whose work in enhancing protein yield from cell cultures has significant implications for biotechnology. His innovative approaches and collaborations continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile